EAN: | 9789811304958 |
---|---|
Auflage: | 002 |
Sachgruppe: | Medizin |
Sprache: | Englisch |
Seitenzahl: | 260 |
Produktart: | Gebunden |
Herausgeber: | Bornstein, Gadi G. Klakamp, Scott L. Tabrizi, Mohammad A. |
Veröffentlichungsdatum: | 12.11.2018 |
Untertitel: | Translational Considerations & Challenges |
Schlagworte: | Apotheke - Apotheker Arznei / Arzneimittellehre Biochemie Chemie / Biochemie Krankenpflege Pflege / Krankenpflege Pharmakologie |
160,49 €*
Die Verfügbarkeit wird nach ihrer Bestellung bei uns geprüft.
Bücher sind in der Regel innerhalb von 1-2 Werktagen abholbereit.
With a key focus on recent developments and advances in the field, this book provides in-depth coverage of topics fundamental to the development of targeted therapeutics. The expansion of targeted modalities in rapidly evolving therapeutic areas, such as immune-oncology, and developments with respect to combination therapies, novel technologies, and the therapeutic application of antibody-drug conjugates, are presented. Additionally, the book builds upon topics discussed in the first edition (2012) where recent innovations warrant elaboration. This, the second edition of Development of Antibody-Based Therapeutics: Translational Considerations, represents a comprehensive evaluation of progress in the field, which sits alongside the first edition to inform, in detail, professional and academic researchers, as well as graduate students.